Evidence mapPaperPMID 42395031Full record

ArticleBrain, behavior, & immunity - health2026

Molecular, cellular and network mapping of brain structural deviations in patients with Post-COVID19 syndrome.

Daniel Martins, Ziyuan Cai, Nicole Mariani, Alessandra Borsini, Valeria Mondelli, Brandi Eiff, Silvia Rota, Daniel van Wamelen, Timothy Nicholson, Laila Rida and 8 more

Abstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Daniel MartinsDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Ziyuan CaiDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Nicole MarianiDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Alessandra BorsiniDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Valeria MondelliDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Brandi EiffDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Silvia RotaDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Daniel van WamelenDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Timothy NicholsonDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Laila RidaDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Adam HampshireDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Lia FernandesDepartment of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Portugal.
Fernando ZelayaDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Aleksandra PodlewskaKing's College Hospital NHS Foundation Trust, UK.
Ray ChaudhuriKing's College Hospital NHS Foundation Trust, UK.
Federico TurkheimerDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Steven C R WilliamsDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Mattia VeroneseDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-COVID-19 syndrome encompasses persistent cognitive, neurological, and psychiatric symptoms following SARS-CoV-2 infection, profoundly affecting global quality of life. Clarifying the neurobiological basis of these symptoms is vital for effective therapeutic interventions. This study utilized normative modelling of brain structure ("CentileBrain") to quantify subject-level deviations in cortical thickness, surface area, and subcortical volumes among 20 patients experiencing persistent fatigue following mild COVID-19, compared to 20 matched healthy controls. Group-level analyses on deviation scores revealed subtle yet distinct regional alterations in cortical thickness, specifically decreased thickness within orbitofrontal cortices and increased thickness in occipital/sensory cortices. Although at the individual regional level, the proportion of patients exhibiting infranormal or supranormal thickness values was relatively low (<35%) and comparable to controls, deviations frequently clustered within structurally connected circuits, affecting up to 50% more of patients. Spatial analysis of regional cortical thickness alterations correlated significantly with the constitutive expression patterns of TMPRSS2, an essential protein facilitating SARS-CoV-2 cellular entry. Canonical correlation analyses further identified specific cell-type distributions and neuroreceptor densities predictive of regional thickness changes, highlighting neurons and molecular targets associated with serotoninergic, cannabinoid, cholinergic, and glutamatergic signalling pathways. Network-diffusion modelling constrained by a canonical structural connectome significantly outperformed null models based on permuted connectomes and Euclidean distance metrics, identifying posterior-parietal regions as probable initiation points ("seeds") for network-wide structural changes. Seed likelihood correlated positively with TMPRSS2 expression levels, suggesting that these posterior-parietal regions may be particularly susceptible to SARS-CoV-2 infection. This highlights a plausible mechanism where structural alterations could propagate through connected neural networks, although direct evidence of such propagation requires further investigation. These findings provide novel insights into potential mechanisms underlying neural circuit disruptions in post-COVID-19 fatigue and suggest avenues for therapeutic neuromodulation.

Identifiers

PMID42395031
PMCPMC13324840

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.